Urelumab Recruiting Phase 2 Trials for Transitional Cell Carcinoma / Cancer, Bladder Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder